Complement Activation in Alzheimer's Disease Mouse Models
Author Information
Author(s): Maria I Fonseca, Shu-Hui Chu, Alisia M Berci, Marie E Benoit, Douglas G Peters, Yuko Kimura, Andrea J Tenner
Primary Institution: University of California, Irvine
Hypothesis
The complement activation triggered by fibrillar ß-amyloid contributes to the inflammatory reaction that can play a detrimental role in the progression of Alzheimer's disease.
Conclusion
The study suggests that the classical complement pathway may not influence neuropathology in the 3xTg mouse model of Alzheimer's disease, indicating a potential role for the alternative complement pathway.
Supporting Evidence
- 3xTgQ-/- mice showed similar amounts of fibrillar amyloid and hyperphosphorylated tau as the C1q-sufficient 3xTg.
- Properdin, a component of the alternative complement pathway, was associated with plaques in all models.
- The presence of C1q had no effect on neuropathological and pro-inflammatory markers in the 3xTg model.
Takeaway
This study looked at how different parts of the immune system, called complement pathways, affect brain problems in mice with Alzheimer's. It found that one pathway might not be as important as previously thought.
Methodology
The study involved generating and analyzing different mouse models of Alzheimer's disease, specifically focusing on the 3xTg and 3xTgQ-/- mice, and assessing their pathology through various immunohistochemical techniques.
Potential Biases
The study primarily used female mice, which may limit the generalizability of the findings to male mice.
Limitations
The variability in pathological markers among individual animals suggests genetic factors may influence results.
Participant Demographics
The study focused on female 3xTg and 3xTgQ-/- mice aged between 7 to 18 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website